Baht 5.2 million due to last year consultation fees on Transforming organization towards sustainability while no other expense incurred in this year. Profit for the period The Company and its
results for the year ended 31th December 2018, compared to those for the same period ended 31th December 2017. The consolidated financial statements reported a net profit of Baht 18.46 million and net loss
shareholders prior to the end of the offering period, the offered price for GLOW shares shall be decreased in the amount equivalent to such dividend or any other rights, and the shareholders who have expressed
total revenue at 180.99 million Baht, down 111.95 million Baht, or a decrease of 38.22%, compared with the same period of previous year. The Company had a net profit of 1.96 million Baht, an increase of
% from 29.71% booked for the same period of last year. The SG&A expenses increased by 0.31 million baht or 0.74% on a year-on- year basis to 41.75 million baht. Financial costs amounted to 1.49 million
Company”) would like to summarize its Q1/2019 operating performance for the period ending 31 March 2019 as follows: The Company and its subsidiaries’ posted a net profit of Baht 32.82 million for the Q1
Exchange of Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the three-month period at the end of 31st March 2019 as follows. Summary
for the period of 20 years. The purpose of the loan is to use in the construction and development of the 275 megawatts Riau Combined-Cycle Power Plant Project in the Republic of Indonesia, with a 20